Abstract
In this study, we use primary embryonic fibroblasts derived from cyclooxygenase-deficient transgenic embryos to further investigate the role of the two cyclooxygenases, cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2), in the process of neoplastic transformation. Cells with either, neither, or both of the cyclooxygenases were transformed by Ha-ras and/or SV40. Our results show that when a cyclooxygenase enzyme is present, the transformed cells have marked increases in COX-2 and/or COX-1 expression. Nevertheless, each type of cell, deficient in either or both cyclooxygenases, can be readily transformed at almost equal efficiency. Different nonsteroidal antiinflammatory drugs (NSAIDs) were used to examine their possible antineoplastic effects on the transformed cells, which have various levels of expression of COX-1 or COX-2. Our results show that NSAIDs suppress the colony formation in soft agar in a dosage-dependent manner in the absence of the cyclooxygenase(s). Thymidine incorporation and apoptosis analyses further demonstrate that the NSAIDs are effective in the cyclooxygenase-null cells. Our findings with cyclooxygenase knockout cells confirm recent reports that some of the antiproliferative and antineoplastic effects of NSAIDs are independent of the inhibition of either COX-1 or COX-2. They also show that transformation is independent of the status of cyclooxygenase expression, suggesting that the involvement of the cyclooxygenases in tumorigenesis may occur at later steps.
References
46
Referenced
207
10.1016/S0021-9258(18)54491-4
/ J. Biol. Chem. / A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein by O'Banion (1991)10.1073/pnas.89.11.4888
/ Proc. Natl. Acad. Sci. USA. / cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase by O'Banion (1992)10.1016/S0021-9258(18)98774-0
/ J. Biol. Chem. / Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters by Kujubu (1991)10.1016/S0021-9258(17)37223-X
/ J. Biol. Chem. / Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo by Pritchard (1994){'key': '2023072508545013900_R5', 'first-page': '101', 'article-title': 'Anti-inflammatory glucocorticoid actioninhibition of griPGHS, a new cyclooxygenase', 'volume': '6', 'author': 'Winn', 'year': '1993', 'journal-title': 'J. Lipid Mediat.'}
/ J. Lipid Mediat. / Anti-inflammatory glucocorticoid actioninhibition of griPGHS, a new cyclooxygenase by Winn (1993){'key': '2023072508545013900_R6', 'first-page': '125', 'article-title': 'Prostaglandin synthase 2', 'volume': '1229', 'author': 'Herschman', 'year': '1992', 'journal-title': 'Biochim. Biophys. Acta.'}
/ Biochim. Biophys. Acta. / Prostaglandin synthase 2 by Herschman (1992)10.1073/pnas.87.9.3373
/ Proc. Natl. Acad. Sci. USA. / Persistent induction of cyclooxygenase in p60 v-src-transformed 3T3 fibroblasts by Han (1990)10.1016/0016-5085(94)90246-1
/ Gastroenterology. / Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas by Eberhart (1994)10.1006/abbi.1996.0271
/ Arch. Biochem. Biophys. / Prostaglandin synthase 2 expression in epidermal growth factor-dependent proliferation of mouse keratinocytes by Loftin (1996){'key': '2023072508545013900_R10', 'first-page': '733', 'article-title': 'G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2', 'volume': '56', 'author': 'DuBois', 'year': '1996', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2 by DuBois (1996)10.1016/0092-8674(95)90127-2
/ Cell. / Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 by Tsujii (1995)10.1016/S0092-8674(00)81988-1
/ Cell. / Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) by Oshima (1996)10.1172/JCI119400
/ J. Clin. Invest. / Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2 by Sheng (1996)10.1016/S0016-5085(97)99999-6
/ Gastroenterology. / Nonsteroidal anti-inflammatory drugs and colorectal cancerevolving concepts of their chemopreventive actions by Shiff (1997)10.1016/0092-8674(95)90126-4
/ Cell. / Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration by Langenbach (1995)10.1016/0092-8674(95)90125-6
/ Cell. / Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse by Morham (1995)10.1006/abbi.1996.0257
/ Arch. Biochem. Biophys. / Relative activities of retrovirally expressed murine prostaglandin synthase-1 and -2 depend on source of arachidonic acid by Chulada (1996)10.1016/S0021-9258(17)40703-4
/ J. Biol. Chem. / Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages by Reddy (1994)10.1084/jem.187.4.517
/ J. Exp. Med. / Compensatory prostaglandin E2 biosynthesis in cyclooxygenase 1 or 2 null cells by Kirtikara (1998)10.1016/S0016-5085(97)70007-6
/ Gastroenterology. / A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells by Sheng (1997)10.1038/304596a0
/ Nature. / Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes by Land (1983)10.1073/pnas.92.17.7961
/ Proc. Natl. Acad. Sci. USA. / Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts by Lu (1995)10.1006/excr.1996.0023
/ Exp. Cell Res. / Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cellseffects on cell cycle and apoptosis by Shiff (1996)10.1038/sj.onc.1202085
/ Oncogene. / Sulindac sulfide inhibits Ras signaling by Herrmann (1998)10.1073/pnas.95.2.681
/ Proc. Natl. Acad. Sci. USA. / Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis by Chan (1998){'key': '2023072508545013900_R26', 'volume-title': 'AHFS Drug Information 97', 'author': 'McEvoy', 'year': '1997'}
/ AHFS Drug Information 97 by McEvoy (1997){'key': '2023072508545013900_R27', 'first-page': '241', 'article-title': 'Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation', 'volume': '8', 'author': 'Duggan', 'year': '1980', 'journal-title': 'Drug Metab. Dispos.'}
/ Drug Metab. Dispos. / Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation by Duggan (1980){'key': '2023072508545013900_R28', 'first-page': '4682', 'article-title': 'ras oncogenes in human cancera review', 'volume': '49', 'author': 'Bos', 'year': '1989', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / ras oncogenes in human cancera review by Bos (1989)10.1073/pnas.94.7.3336
/ Proc. Natl. Acad. Sci. USA. / Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential by Beauchamp (1997)10.1074/jbc.272.34.21455
/ J. Biol. Chem. / Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression by Narko (1997)10.1016/S0092-8674(00)81433-6
/ Cell. / Cyclooxygenase regulates angiogenesis induced by colon cancer cells by Tsujii (1998)10.1016/0163-7258(92)90012-O
/ Pharmacol. Ther. / Xenobiotic metabolism by prostaglandin H synthase by Eling (1992)10.1007/BF00666100
/ Cancer Metastasis Rev. / Generation of mutagens during arachidonic acid metabolism by Marnett (1994)10.1073/pnas.94.16.8652
/ Proc. Natl. Acad. Sci. USA. / Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde by Fink (1997){'key': '2023072508545013900_R35', 'first-page': 'G1061', 'article-title': 'Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice', 'volume': '274', 'author': 'Sawaoka', 'year': '1998', 'journal-title': 'Am. J. Physiol.'}
/ Am. J. Physiol. / Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice by Sawaoka (1998){'key': '2023072508545013900_R36', 'first-page': '3110', 'article-title': 'Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis', 'volume': '55', 'author': 'Piazza', 'year': '1995', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis by Piazza (1995){'key': '2023072508545013900_R37', 'first-page': '267', 'article-title': 'Sulfone metabolite of sulindac inhibits mammary carcinogenesis', 'volume': '57', 'author': 'Thompson', 'year': '1997', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Sulfone metabolite of sulindac inhibits mammary carcinogenesis by Thompson (1997)10.1093/carcin/10.8.1369
/ Carcinogenesis. / A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acid by Carter (1989)10.1016/0006-2952(96)00181-5
/ Biochem. Pharmacol. / Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway by Hanif (1996){'key': '2023072508545013900_R40', 'first-page': '1679', 'article-title': 'Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drugindependence from COX-2 protein expression', 'volume': '3', 'author': 'Elder', 'year': '1997', 'journal-title': 'Clin. Cancer Res.'}
/ Clin. Cancer Res. / Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drugindependence from COX-2 protein expression by Elder (1997)10.1016/S0304-3835(97)00361-3
/ Cancer Lett. / Cyclooxygenase-2 selective antagonists do not inhibit growth of colorectal carcinoma cell lines by Murphy (1998)10.1002/anr.1780320102
/ Arthritis Rheum. / The mechanisms of action of nonsteroidal anti-inflammatory drugs by Abramson (1989)10.1074/jbc.272.6.3406
/ J. Biol. Chem. / Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs by Lehmann (1997)10.1126/science.270.5244.2017
/ Science. / The effect of sodium salicylate and aspirin on NF-kappa B by Frantz (1995){'key': '2023072508545013900_R45', 'first-page': '4245', 'article-title': 'NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells', 'volume': '58', 'author': 'Liu', 'year': '1998', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells by Liu (1998)10.1016/S0014-2999(98)00679-7
/ Eur. J. Pharmacol. / Induction of apoptotic DNA fragmentation by nonsteroidal anti-inflammatory drugs in cultured rat gastric mucosal cells by Kusuhara (1998)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 12:48 p.m.) |
Deposited | 2 years, 1 month ago (July 25, 2023, 6:05 a.m.) |
Indexed | 2 months ago (July 1, 2025, 9:48 a.m.) |
Issued | 26 years ago (Aug. 16, 1999) |
Published | 26 years ago (Aug. 16, 1999) |
Published Online | 26 years ago (Aug. 16, 1999) |
Published Print | 26 years ago (Aug. 16, 1999) |
@article{Zhang_1999, title={Malignant Transformation and Antineoplastic Actions of Nonsteroidal Antiinflammatory Drugs (Nsaids) on Cyclooxygenase-Null Embryo Fibroblasts}, volume={190}, ISSN={1540-9538}, url={http://dx.doi.org/10.1084/jem.190.4.451}, DOI={10.1084/jem.190.4.451}, number={4}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Zhang, Xinping and Morham, Scott G. and Langenbach, Robert and Young, Donald A.}, year={1999}, month=aug, pages={451–460} }